Video Shorts

Balazs Halmos, MD, Answers Josh Sabari, MD

The Mechanism of Action of Evorpacept in Breast Cancer

What Does the Future Hold for Cancer Vaccines in Pancreatic Cancer?

Unpacking Subgroup Data With First-Line Ipatasertib Plus Pembrolizumab in HNSCC

Outlining Questions About the Future of HR+ Breast Cancer Care

Defining the Importance of Real-World Data in Lung Cancer

The Rationale to Wait for Radiographic Progression Before Switching Breast Cancer Therapy

Examining the Cardiovascular Risks of Hormone Therapy in Prostate Cancer

The Importance of Giving the Most Effective Therapy Upfront in TNBC

Explaining ctDNA Analysis Findings From SERENA-6 in Breast Cancer

Targeting FcRH5 in Multiple Myeloma

Why Early CAR T-Cell Therapy Is a Game-Changer in Myeloma

Exploring the Future of Radiopharmaceuticals in Prostate Cancer

Exploring Brenetafusp in Melanoma

Exploring the Next Steps for Belzutifan in RCC

Discussing the Safety of Silicone Breast Implants

Which Lung Cancer Experts Changed Your Mind at 2026 BTG Lung?

The Potential Effect of Daraxonrasib for Pancreatic Cancer Management

Examining a Novel Vaccine in Pancreatic Cancer

Discussing the Biggest Unmet Needs to be Addressed at 2026 BTG Lung

ATLG vs PTCy as GVHD Prophylaxis in Hematologic Malignancies

Outlining the Rationale for an ASCENT-07 Subgroup Analysis in Breast Cancer

Spotlighting the FDA Approval of Palbociclib Plus Trastuzumab for HER2+ Breast Cancer

Exploring the Potential Role of Cancer Vaccines in Pancreatic Cancer

Breaking Down Zanubrutinib Plus Sonrotoclax in MCL and Next Steps for the Combination

Explaining the Significance of the FDA Approval of Pembro Plus EV in MIBC

Targeting PRAME in Melanoma

Would You Rather? With Two Onc Docs!

Explaining the Rationale for the OPTIMA Trial in Early Breast Cancer

Highlighting the Importance of Innovative Glioblastoma Research